Login
value-dx
  • About us
    • What is VALUE-Dx?
    • Governance
    • The Consortium
  • Work Packages
    • Work Package 1
    • Work Package 2
    • Work Package 3
    • Work Package 4
    • Work Package 5
    • Work Package 6
    • Work package 7
  • WAAW Campaign
    • WAAW Campaign 2022
    • WAAW Campaign 2021
    • WAAW Campaign 2020
    • WAAW Campaign 2019
  • News & Events
    • News
    • Events
    • Interviews
  • Publications
    • Communication Resources
    • Scientific Publications
  • Contact
  • VALUE-Dx E-learning Platform
  • Search
  • Menu Menu
  • About us
    • What is VALUE-Dx?
    • Governance
    • The Consortium
  • Work Packages
    • Work Package 1
    • Work Package 2
    • Work Package 3
    • Work Package 4
    • Work Package 5
    • Work Package 6
    • Work package 7
  • WAAW Campaign
    • WAAW Campaign 2022
    • WAAW Campaign 2021
    • WAAW Campaign 2020
    • WAAW Campaign 2019
  • News & Events
    • News
    • Events
    • Interviews
  • Publications
    • Communication Resources
    • Scientific Publications
  • Contact
  • VALUE-Dx E-learning Platform

Archive for month: October, 2020

You are here: Home1 / 20202 / October
News

Antimicrobial Resistance Survey – Joint Action by JPIAMR and VALUE-Dx

October 7, 2020/by Daniele Pazzola
Read more
https://www.value-dx.eu/wp-content/uploads/2019/09/VALUE-Dx_logo_white4.png 428 1226 Daniele Pazzola https://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.png Daniele Pazzola2020-10-07 07:37:272020-11-18 08:34:05Antimicrobial Resistance Survey – Joint Action by JPIAMR and VALUE-Dx

Pages

  • Activity
  • Activity
  • ADEQUATE trial – password restricted area
  • All Press releases
  • Communication Resources
  • Communications Folder
  • Contact
  • Development – do not delete – WAAW Campaign Map 2
  • ERS E-learning
  • EVENTS
  • General Assembly
  • General Folder
  • Groups
  • Groups 2
  • Homepage
  • Interviews-page
  • Join Us
  • Login-page
  • Member Login
  • Members
  • NEWS
  • News releases -all
  • Password Reset
  • Privacy Policy
  • Profile
  • PRUDENCE trial – password restricted area
  • Publications
  • Registration
  • Sample Page
  • Testpagemembers
  • The Consortium
  • WAAW Campaign 2019
  • WAAW Campaign 2020
  • WAAW Campaign 2021
  • WAAW Campaign 2022
  • What is VALUE-Dx?
  • Work Package 1
  • Work Package 2
  • Work Package 3
  • Work Package 4
  • Work Package 5
  • Work Package 6
  • Work package 7
  • WP1-logged in area
  • WP2-logged in area
  • WP3- logged in area
  • WP4 – logged in area
  • WP5- logged in area
  • WP6- logged in area
  • WP7-logged in area

Categories

  • Interviews
  • News
  • Press
  • Uncategorized
  • Upcoming events – internal

Archive

  • March 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • July 2022
  • January 2022
  • December 2021
  • November 2021
  • August 2021
  • April 2021
  • March 2021
  • November 2020
  • October 2020
  • September 2020
  • June 2020
  • April 2020
  • January 2020
  • November 2019
  • October 2019
  • September 2019
  • July 2019

Social Media

Twitter
LinkedIn

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 820755. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and bioMérieux SA, Janssen Pharmaceutica NV, Accelerate Diagnostics S.L., Abbott, Bio-Rad Laboratories, BD Switzerland Sàrl, and The Wellcome Trust Limited.

Copyright - Value-Dx - Any dissemination of results must indicate that it reflects only the author's view and that the JUis not responsible for any use that may be made of the information it contains.
Scroll to top